Jan 1, 1976

Central regulation of blood eosinophilia by the beta-adrenergic system in rats

International Archives of Allergy and Applied Immunology
A Szczeklik, Z Podolec


The effect of isoprenaline and three different beta-adrenergic blocking agents on blood eosinophilia was evaluated in the rat. Eosinopenic effect of isoprenaline was antagonized by intraperitoneal pretreatment with propranolol and by high but not low doses of practolol. Sotalol, a beta-blocker which in contrast to propranolol does not penetrate the blood-brain barrier, did not affect the eosinophil count when injected intraperitoneally, but produced a marked increase in number of circulating eosinophils following intracerebroventricular injection. Intraperitoneal administration of isoprenaline and propranolol as well as intracerebroventricular injection of sotalol did not affect eosinophil count in adrenalectomized or hypophysectomized rats. These results suggest that beta-adrenergic agents regulate the number of circulating eosinophils through a central mechanism and that presence of both hypophysis and adrenal glands is required for this action.

  • References
  • Citations3


  • We're still populating references for this paper, please check back later.
  • References
  • Citations3


Mentioned in this Paper

Blood - Brain Barrier Anatomy
Adrenergic beta-Agonists
Disorder Characterized by Eosinophilia
Eosinophilic Disorder
Eosinophils as Percentage of Blood Leukocytes
Specimen Type - Eosinophils

About this Paper

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.